Latest Antiprotozoal agents Stories
PITTSBURGH, May 29, 2014 /PRNewswire/ -- Mylan Inc.
DUBLIN and LAVAL, Quebec, March 25, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S.
Researchers have identified fexinidazole as a possible, much-needed, new treatment for the parasitic disease visceral leishmaniasis.
A new study published in the open-access journal PLoS Neglected Tropical Diseases on September 6th presents a key advance in developing a safer cure for sleeping sickness.
Scientists are hoping that heat therapy could eventually replace a complex drug regimen as the first-line treatment of a parasitic skin infection common in tropical and subtropical regions of the world.
Visceral Leishmaniasis program expands to support South Asian regional elimination efforts. San Francisco, CA (PRWEB) November 24, 2010 The Institute for OneWorld Health (iOWH), the US based non-profit pharmaceutical company with offices in San Francisco, USA and India that develops drugs for people with neglected infectious diseases in the developing world, today announced a new program in Nepal and Bangladesh to develop a therapy for Visceral Leishmaniasis (VL) available through a grant...
SCHAUMBURG, Ill., May 17 /PRNewswire/ -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of all lots of metronidazole injection, USP 500mg / 100mL (NDC number 25021-131-82) manufactured by Claris Lifesciences and distributed by Sagent.
A single session of heat therapy using the ThermoMedâ„¢ device appears to be as effective as a 10-day intravenous course of sodium stibogluconate (Pentostam) for the treatment of Leishmania major skin lesions.
Antimicrobial treatments for bacterial vaginosis (BV) are effective, but taking lactobacillus tablets alongside metronidazole antibiotic therapy increases effectiveness over taking this antibiotic alone, according to a Cochrane Systematic Review.
SAN ANTONIO, March 5 /PRNewswire/ -- A plentiful, inexpensive, topical compound is as effective at treating the skin lesions of Middle Eastern and African leishmaniasis as is the standard therapy, a less-available, costlier compound injected into lesions.
- totally perplexed and mixed up.